WATCH: Advocates Urge Congress to Increase Access to Innovative Diagnostics

Effectively treating a disease begins with an accurate diagnosis, but current Medicare reimbursement policy limits patient access to many innovative diagnostic radiopharmaceuticals that can diagnose and monitor conditions such as Parkinson’s disease, advanced cardiac disease, cancers of the prostate, breast, and brain. The technology has also been integral to validating an Alzheimer’s diagnosis for many patients, like Geri Taylor, by confirming the presence of amyloid plaques in the brain.

Watch as Geri’s husband, Jim, talks about why Congressional action is needed to improve access to these critical drugs:

Please join Jim, Geri and countless other advocates in asking Congress to pass the Facilitating Innovative Nuclear Diagnostics (FIND) Act and give clinicians all the tools necessary to diagnose Alzheimer’s disease and many others.

Click here to send you letter today.

More Articles

Congress Has 100 Days to Act

September 23, 2019

The medical device tax will go back into effect at the end of this year. As the clock…

Read More

Recognizing Innovations in Treatment During Prostate Cancer Awareness Month

September 13, 2019

About one in 9 men will be diagnosed with prostate cancer during their lifetime. This disease is also…

Read More

In the Midst of August Recess, the Clock Continues to Tick.

August 13, 2019

August Recess is upon us, and, as always, homebound lawmakers are spending their time holding town halls and…

Read More

Patient Leader Erika Hanson Brown Urges the Senate Finance Committee to #RepealDeviceTax

July 8, 2019

Recently, the Senate Finance Committee Health Tax Task Force held a meeting to discuss the medical device tax. While the 2.3%…

Read More